Wolfe Research Downgrades Boston Scientific to Peer Perform

On May 29, Wolfe Research downgraded Boston Scientific Corporation (NYSE:BSX) from Outperform to Peer Perform due to slowing sales growth of its Watchman implant. The firm now forecasts 7% organic growth for BSX in 2027 and a share price in the early $50s.

By Ashar Jawad Mon, June 1, 2026 at 5:14 PM GMT+3 1 min read · Yahoo Finance · June 1, 2026, 14:14 UTC

Wolfe Research Downgrades Boston Scientific to Peer Perform

Tickers: $BSX

Topics: Medical Technology Stock Downgrades

Read the full article at Yahoo Finance

More World news

Canadian Tire Announces Quarterly Dividend of CAD 1.825 Per Share Seeking Alpha · November 12, 2026, 13:58 UTC
Chicago Atlantic BDC Announces $0.34 Per Share Quarterly Dividend Seeking Alpha · November 12, 2026, 13:59 UTC
William Blair Upgrades AMD to Outperform Amid Leadership Crisis at Nvidia CNBC · November 12, 2026, 13:56 UTC
HawkEye 360 Secures $135 Million in New Global Contracts Seeking Alpha · November 12, 2026, 13:55 UTC
Databento Secures $100 Million Series C Funding at $1.1 Billion Valuation PR Newswire · November 12, 2026, 13:57 UTC
Annex Brands Announces Franchise Renewal for Postal Connections in Fort Mohave, Arizona PR Newswire · November 12, 2026, 13:58 UTC
Nvidia CEO Jensen Huang Resigns Following Personal Scandals and Espionage Allegations The Verge · November 12, 2026, 13:53 UTC
AMD and PsiQuantum Partner to Develop Fault-Tolerant Quantum Computing Infrastructure Seeking Alpha · November 12, 2026, 13:44 UTC
Nvidia CEO Jensen Huang Resigns; CFO Colette Kress Appointed Interim CEO Seeking Alpha · November 12, 2026, 13:50 UTC
Aktis Oncology Reports Q3 Revenue Growth and Significant Increase in Cash Reserves Seeking Alpha · November 12, 2026, 13:50 UTC